MedPath

ERBITUX

ERBITUX

Approved
DIN Number

02271249

Drug Class

Human

Market Date

Oct 28, 2008

Company
HC

imclone, llc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02271249
AIG Number0151441001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FE01 CETUXIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CETUXIMABActive
Strength: 2 MG / ML
Monograph: CETUXIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.